GAMMA Investing’s Unicycive Therapeutics UNCY Stock Holding History

GAMMA Investing’s Portfolio UNCY Stock Details UNCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.56K	Buy	+759	New	+$3.93K	﹤0.01%	3779

Other funds holding UNCY

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $5.45B AUM 19.52% 1-Year Est. Return

Macroview Investment Management Bethesda, Maryland $167M AUM 15.37% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

TFC Financial Management Boston, Massachusetts $893M AUM 15.25% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's UNCY Position: Q3 2026 in Review

GAMMA Investing opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 759 shares worth $3.56K. The stake represents ﹤0.01% of the portfolio and ranks #3779 among its holdings.

15 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

GAMMA Investing held 759 shares of Unicycive Therapeutics worth $3.56K as of Q3 2026.
Unicycive Therapeutics was a new GAMMA Investing position in Q3 2026.
Unicycive Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3779 holding.
15 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.